# FDA Inspection 1242681 - Concord Hospital, Inc./ BB - June 26, 2024

Source: https://www.keypedia.com/records/fda_inspections/concord-hospital-inc-bb/27f3cf2d-acd5-4598-b4cc-f3aa6879f069
Source feed: FDA_Inspections

> FDA Inspection 1242681 for Concord Hospital, Inc./ BB on June 26, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1242681
- Company Name: Concord Hospital, Inc./ BB
- Inspection Date: 2024-06-26
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1036604 - 2017-12-12](https://www.keypedia.com/records/fda_inspections/concord-hospital-inc-bb/1b6a1ef5-9e7a-4883-9a6b-04e9129914c7)
- [FDA Inspection 952162 - 2015-12-01](https://www.keypedia.com/records/fda_inspections/concord-hospital-inc-bb/62ec51a5-6f26-4d57-a954-5efa509a199a)
- [FDA Inspection 779529 - 2012-05-01](https://www.keypedia.com/records/fda_inspections/concord-hospital-inc-bb/417a6340-badc-4fc2-9d26-eafa064b90f5)
- [FDA Inspection 661824 - 2010-05-10](https://www.keypedia.com/records/fda_inspections/concord-hospital-inc-bb/69f09298-8de0-49c2-8525-e71326b6bb7a)

Company: https://www.keypedia.com/companies/concord-hospital-inc-bb/9a6c6fb0-15fb-4e3d-9ea9-da55a1654678

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d